# Identification of BCR::ABL1 Mutations by Digital PCR in CML

> **NCT07158294** · NA · NOT_YET_RECRUITING · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia (CML)

## Interventions

- **OTHER:** Peripheral blood withdrawal for BCR::ABL1 mutations testing

## Key facts

- **NCT ID:** NCT07158294
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07158294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07158294, "Identification of BCR::ABL1 Mutations by Digital PCR in CML". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07158294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*